e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Respiratory disorders of the newborn
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology
M. Tservistas, C. Fuchs, R. Egle, U. Fleschhut, S. Ederer, A. Nikolai, K. Reul, S. Maresch, G. Hochwimmer, M. Keller, M. Knoch (Munich, Germany)
Source:
Annual Congress 2009 - Respiratory disorders of the newborn
Session:
Respiratory disorders of the newborn
Session type:
Thematic Poster Session
Number:
4052
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Tservistas, C. Fuchs, R. Egle, U. Fleschhut, S. Ederer, A. Nikolai, K. Reul, S. Maresch, G. Hochwimmer, M. Keller, M. Knoch (Munich, Germany). Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology. Eur Respir J 2009; 34: Suppl. 53, 4052
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma
Risk factors associated with the development of interstitial lung abnormalities
New inhaler devices: the good, the bad, and the ugly
Related content which might interest you:
A new tool for monitoring patient adherence with aerosol therapy using an eflow nebulizer system
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Validation and clinical application of a newly developed high-concentration oxygen-delivery device with a jet nebulizer function
Source: Annual Congress 2010 - COPD: management
Year: 2010
In vitro
characterisation of a novel electronic nebulizer utilising a customised single dose bfs-vial to improve handling and delivery performance
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009
Improvement of QVAR delivery through a better sorting of drug particles: development of an innovative and easy-to-use spacer
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008
In vitro performance of the prodose AAD® handheld - a new portable aerosol delivery system
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004
Impact of different ventilator parameters on in-vitro aerosol performance of a novel nebulizer for ventilated patients
Source: Annual Congress 2009 - Airway management, mechanical ventilation and muscle weakness
Year: 2009
Assessment of two different methods of bronchodilators delivery during noninvasive ventilation. Experimental in vivo approach
Source: Eur Respir J 2004; 24: Suppl. 48, 315s
Year: 2004
Use of a telemedicine application to examine patient logging system data from a 3-month use of an adaptive aerosol delivery system by patients with COPD
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008
Bench performance and lung deposition of the I-neb adaptive aerosol delivery system
Source: Annual Congress 2007 - New developments in thoracic imaging modalities and illustrated thorax pathologies
Year: 2007
Improvement of pulmonary drug delivery by eFlow™, a novel electronic inhaler making use of a vibrating membrane principle
Source: Eur Respir J 2003; 22: Suppl. 45, 472s
Year: 2003
Reduction of treatment time for nebulized treatments using a new adaptive aerosol delivery mode
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
Recommended approaches to minimize aerosol dispersion of COVID during noninvasive ventilatory support can deteriorate ventilator performances: a benchmark comparative study
Source: Virtual Congress 2021 – New trends in non-invasive respiratory support
Year: 2021
The new jet nebuliser family PARI LC SPRINT: a new concept for rapid drug delivery targeting different age groups
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006
Mesh nebulizer capabilities in aerosolizing a wide range of novel pharmaceutical formulations
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
Computer simulations of asthma with applications to the design of customized nebulizers
Source: Eur Respir J 2003; 22: Suppl. 45, 277s
Year: 2003
Eliminating in-vitro drug-drug interactions in dual and triple fixed-dose combination therapies using a novel cosuspension metered dose inhaler platform
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Developing a novel
in vitro
3D airway model to provide a viable alternative to animal use in asthma research
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Aerosol delivery characteristics from a new jet nebulizer in comparison with commercially available jet nebulizers
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept